Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $56.31 in the prior trading day, Hims & Hers Health Inc (NYSE: HIMS) closed at $57.87, up 2.77%. In other words, the price has increased by $2.77 from its previous closing price. On the day, 25.84 million shares were traded. HIMS stock price reached its highest trading level at $59.27 during the session, while it also had its lowest trading level at $56.76.
Ratios:
Our goal is to gain a better understanding of HIMS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 112.30. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.85.
On June 04, 2025, Needham reiterated its Buy rating and also lowered its target price recommendation from $61 to $65. TD Cowen Downgraded its Buy to Hold on April 29, 2025, while the target price for the stock was maintained at $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 01 ’25 when Chi Michael sold 250 shares for $56.00 per share. The transaction valued at 14,000 led to the insider holds 291,439 shares of the business.
Chi Michael bought 250 shares of HIMS for $14,000 on Oct 01 ’25. On Sep 29 ’25, another insider, Okupe Oluyemi, who serves as the Chief Financial Officer of the company, sold 85,000 shares for $60.20 each. As a result, the insider received 5,116,924 and left with 70,232 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 13079752704 and an Enterprise Value of 12979526656. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.43, and their Forward P/E ratio for the next fiscal year is 73.29. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.50 while its Price-to-Book (P/B) ratio in mrq is 23.22. Its current Enterprise Value per Revenue stands at 6.446 whereas that against EBITDA is 81.044.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.22, which has changed by 2.276897 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $16.05. The 50-Day Moving Average of the stock is 11.59%, while the 200-Day Moving Average is calculated to be 32.15%.
Shares Statistics:
The stock has traded on average 29.80M shares per day over the past 3-months and 24768420 shares per day over the last 10 days, according to various share statistics. A total of 217.38M shares are outstanding, with a floating share count of 202.67M. Insiders hold about 10.33% of the company’s shares, while institutions hold 77.77% stake in the company. Shares short for HIMS as of 1757894400 were 66534489 with a Short Ratio of 2.23, compared to 1755216000 on 70218527. Therefore, it implies a Short% of Shares Outstanding of 66534489 and a Short% of Float of 36.480000000000004.
Earnings Estimates
The market rating for Hims & Hers Health Inc (HIMS) is a result of the insights provided by 5.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.26, with high estimates of $0.31 and low estimates of $0.17.
Analysts are recommending an EPS of between $1.24 and $0.78 for the fiscal current year, implying an average EPS of $1.07. EPS for the following year is $1.38, with 5.0 analysts recommending between $1.77 and $0.99.
Revenue Estimates
12 analysts predict $578.99M in revenue for. The current quarter. It ranges from a high estimate of $590.87M to a low estimate of $567.56M. As of. The current estimate, Hims & Hers Health Inc’s year-ago sales were $401.56MFor the next quarter, 12 analysts are estimating revenue of $629.41M. There is a high estimate of $685.04M for the next quarter, whereas the lowest estimate is $592.7M.
A total of 14 analysts have provided revenue estimates for HIMS’s current fiscal year. The highest revenue estimate was $2.41B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.34B. In the same quarter a year ago, actual revenue was $1.48BBased on 13 analysts’ estimates, the company’s revenue will be $2.8B in the next fiscal year. The high estimate is $3B and the low estimate is $2.5B.
